-+ 0.00%
-+ 0.00%
-+ 0.00%

Insights into Tarsus Pharmaceuticals Q4 Earnings

Benzinga·02/23/2026 21:06:09
Listen to the news

Tarsus Pharmaceuticals (NASDAQ:TARS) just disclosed its Q4 earnings on Monday, February 23, 2026 at 04:05 PM.

Here's a brief overview of the earnings report.

Earnings

Tarsus Pharmaceuticals missed estimated earnings by -185.71%, reporting an EPS of $-0.2 versus an estimate of $-0.07.

Revenue was up $85.26 million from the same period last year.

Overview of Past Earnings

The company beat on EPS by $0.04 in the previous quarter, leading to a 4.62% drop share price change the next day.

Here's a look at Tarsus Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.34 -0.35 -0.63 -0.82
EPS Actual -0.30 -0.48 -0.64 -0.60
Revenue Estimate 115.32M 94.84M 71.62M 58.80M
Revenue Actual 118.70M 102.66M 78.33M 66.41M

To track all earnings releases for Tarsus Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.